A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. This year’s metric has recorded a Price decrease of -8.58%. However, over the past six months, we’ve seen a weaker performance of 2.90%. The price of ROIV leaped by -10.47% over the last 30 days. And in the last five days, it has fallen by -3.00%.
Roivant Sciences Ltd’s stock market performance has been consistent. The 1-year high for the company’s stock was recorded at $13.06 on 09/09/24, with the lowest value being $9.69 on 02/05/24.
52-week price history of ROIV Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Roivant Sciences Ltd’s current trading price is -17.16% away from its 52-week high, while its distance from the 52-week low is 11.61%. The stock’s price range for this period has been between $9.69 and $13.06. The Healthcare sector company’s shares saw a trading volume of about 2.03 million for the day, which was lower than the average daily volume of 4.76 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Roivant Sciences Ltd (ROIV) has experienced a quarterly decline of -6.36% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 7.87B and boasts a workforce of 908 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 11.68, with a change in price of -1.39. Similarly, Roivant Sciences Ltd recorded 5,452,339 in trading volume during the last 100 days, posting a change of -11.44%.
ROIV’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for ROIV stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.01.
ROIV Stock Stochastic Average
As of today, the raw stochastic average of Roivant Sciences Ltd over the last 50 days is at 14.91%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 26.88%. Further, the company’s Stochastic %K and %D values for the last 20 days were 27.65% and 36.17%, respectively.
